DUSA Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

DUSA 0.0000
price chart
Buy rating on Sun Pharma, target Rs 980: Motilal Oswal
Dusa Pharma reported sales of Rs 430 crore versus Rs 97.5 crore in FY13 (consolidated for three months) while it turned profitable in FY14 (Rs 23.7 crore vs loss of Rs 4.7 crore in FY13).
Buy Sun Pharma, target Rs 980: Motilal Oswal  MoneyGuru India
Related articles »  
WeissLaw LLP Investigates Dusa Pharmaceuticals Inc